176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
View analysts' price targets and recommendations, and compare them with competitors.
$207.00
Analysts expect the stock price to increase by 16.41%.
Buy
Positive consensus among analysts.
Analyze DCF forecasts for the company and compare them with competitors.
339.01B
Revenue has increased from the previous period.
53.59%
Revenue growth rate is unchanged from the previous period.
127.52B
EBITDA has increased from the previous period.
37.62%
EBITDA margin is unchanged from the previous period.
112.17B
EBIT has increased from the previous period.
33.09%
EBIT margin is unchanged from the previous period.
15.35B
Depreciation has increased from the previous period.
230.45B
Total cash has increased from the previous period.
67.98%
Cash percentage is unchanged from the previous period.
52.63B
Receivables have increased from the previous period.
15.52%
Receivables percentage is unchanged from the previous period.
38.91B
Inventories have increased from the previous period.
11.48%
Inventory percentage is unchanged from the previous period.
19.43B
Accounts payable has increased from the previous period.
5.73%
Payables percentage is unchanged from the previous period.
-15.88B
Capital expenditure has increased from the previous period.
-4.68%
CapEx percentage is unchanged from the previous period.
12.05%
WACC is unchanged from the previous period.
12.08%
Cost of equity is unchanged from the previous period.
4.26%
Cost of debt is unchanged from the previous period.
1.66
Beta is unchanged from the previous period.
24.94B
Diluted shares outstanding is unchanged from the previous period.
11.06B
Total debt is unchanged from the previous period.
3.35T
Total equity is unchanged from the previous period.
3.36T
Total capital is unchanged from the previous period.
0.33%
Debt weighting is unchanged from the previous period.
99.67%
Equity weighting is unchanged from the previous period.
107.35B
EBIAT has increased from the previous period.
81.66B
UFCF has increased from the previous period.
4.00%
Long-term growth rate is unchanged from the previous period.
1.62T
Terminal value is unchanged from the previous period.
1.12T
Enterprise value is unchanged from the previous period.
3.78B
Net debt is unchanged from the previous period.
1.12T
Equity value is unchanged from the previous period.
44.94
Equity value per share is unchanged from the previous period.
Analyze analyst forecasts for the company and compare them with competitors.
309.37B
The estimated revenue has increased from the previous period.
137.92B
The estimated EBITDA has increased from the previous period.
6.96
The estimated EPS has increased from the previous period.
172.64B
The estimated net income has increased from the previous period.
125.19B
The estimated EBIT has increased from the previous period.
22.13B
The estimated SG&A expenses have decreased from the previous period.
